DOCSLIB.ORG

Concurrent Angiomyolipoma and Renal Cell Neoplasia: a Study of 36 Cases Rafael E

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Concurrent Angiomyolipoma and Renal Cell Neoplasia: a Study of 36 Cases Rafael E Concurrent Angiomyolipoma and Renal Cell Neoplasia: A Study of 36 Cases Rafael E. Jimenez, M.D., John N. Eble, M.D., Victor E. Reuter, M.D., Jonathan I. Epstein, M.D., Andrew L. Folpe, M.D., Mariza de Peralta-Venturina, M.D., Pheroze Tamboli, M.D., I. David Ansell, M.D., David J. Grignon, M.D., Robert H. Young, M.D., Mahul B. Amin, M.D. Departments of Pathology of Emory University Hospital, Atlanta, Georgia (REJ, ALF, MBA); Indiana University, Indianapolis, Indiana (JNE); Memorial Sloan-Kettering Cancer Center, New York, New York (VER); John Hopkins Hospital, Baltimore, Maryland (JIE); Henry Ford Hospital, Detroit, Michigan (MPV); M.D. Anderson Cancer Center, Houston, Texas (PT); Nottingham City Hospital, Nottingham, United Kingdom (IDA); Harper Hospital and the Karmanos Cancer Institute, Detroit, Michigan (DJG); and Massachusetts General Hospital, Boston, Massachusetts (RHY) neoplasms studied were negative for HMB-45, Little is known about the association of angiomyo- whereas all 25 angiomyolipomas studied were lipoma and adult renal-cell neoplasia. We studied positive. the clinicopathologic features of 36 patients with concurrent angiomyolipoma and renal-cell neopla- KEY WORDS: Angiomyolipoma, Collision neo- sia from the consultation and surgical pathology plasms, Kidney, Oncocytoma, Renal cell carcinoma, files of nine institutions. HMB-45 immunoreactivity Renal cell neoplasia, Clear cell carcinoma. was analyzed in both neoplasms. Twenty-five spo- Mod Pathol 2001;14(3):157–163 radic cases of patients with angiomyolipoma and renal-cell neoplasia and 11 cases of patients with The occurrence of angiomyolipoma in association tuberous sclerosis, as defined by Gomez’ criteria, with a renal-cell neoplasm is uncommon, with only had mean ages of 59 and 53 years, respectively, and approximately 50 cases reported (1–37). Although female–male ratios of 2:1 and 5:1, respectively. The angiomyolipomas are extremely common in pa- mean size of the angiomyolipomas was 1 cm in the tients with the tuberous sclerosis complex (38), it is sporadic cases and 3 cm in those patients with tu- unclear whether patients with tuberous sclerosis berous sclerosis (medians: 0.5 and 3 cm, respec- have more renal-cell neoplasms than the general ؍ tively, P .002). The mean sizes of the renal-cell population. neoplasms were 5 cm in sporadic cases and 6 cm in Our understanding of the biology and clinical patients with tuberous sclerosis (medians: 4 and 5 behavior of angiomyolipoma and renal-cell neopla- ؍ cm, respectively; P .88). In both clinical settings, sia has recently been augmented by several impor- angiomyolipoma was more commonly the inciden- tant developments. There is strong evidence that tal tumor. Clear-cell (conventional) renal-cell carci- angiomyolipomas, for a long time considered to be noma was the most common renal-cell neoplasm in hamartomatous, are actually neoplasms (39, 40). both groups of patients, accounting for approxi- The morphologic spectrum of angiomyolipoma has mately two thirds of the tumors. In patients with been recently expanded to include an epithelioid tuberous sclerosis, 27% of renal-cell neoplasms variant, which is capable of a more aggressive be- were oncocytomas, compared with 8% in sporadic havior than the classic form (41–43). Further, the ؍ cases (P .15). Papillary neoplasia, chromophobe, recent description of the perivascular epithelioid and collecting-duct renal-cell carcinoma were cell family of tumors (44), to which angiomyoli- found only in sporadic cases. All of the 22 renal-cell poma belongs, has expanded our knowledge of en- tities that would fall into the differential diagnosis of angiomyolipoma and renal-cell neoplasms. Sim- Copyright © 2001 by The United States and Canadian Academy of ilarly, our knowledge of tuberous sclerosis has been Pathology, Inc. VOL. 14, NO. 3, P. 157, 2001 Printed in the U.S.A. strengthened by the definition of a constellation of Date of acceptance: December 5, 2000. Presented in part at the 89th United States and Canadian Academy of phenotypic diagnostic criteria and the discovery of Pathology Annual Meeting, New Orleans, LA, March 21–31, 2000. the genes involved in its pathogenesis (45–47). Last, Address reprint requests to: Mahul B. Amin, M.D., Emory University Hospital, 1364 Clifton Road, N.E., G-167, Atlanta, GA 30322; e-mail: our understanding of the biologic potential of [email protected]; fax: 404-712-0148. renal-cell neoplasms has been recently expanded 157 with the adoption of a widely accepted classifica- RESULTS tion (48) that is based on distinct histologic features that correlate closely with consistent genetic A total of 36 cases of coexistent renal-cell neopla- abnormalities. sia and angiomyolipoma were identified from nine We undertook a detailed clinicopathologic study institutions and/or consultation files of the authors. to ascertain the frequency of the concurrence of Eighteen cases from five institutions were identified angiomyolipomas and renal-cell neoplasms in the from a review of approximately 2160 nephrecto- same patient, whether any particular histologic mies performed for a renal mass, suggesting an type of renal-cell neoplasm is more frequently as- incidence of slightly less than 1% (data were un- sociated with angiomyolipomas, and whether the available for the remaining four institutions). Clin- clinical presentation or behavior of either neo- ical features are summarized in Table 1. In one plasm is different compared with when they oc- case, the renal-cell neoplasm preceded a contralat- cur in isolation. Furthermore, we studied whether eral angiomyolipoma by 11 months, whereas in 35 there was any difference in the presentation or cases, both neoplasms were diagnosed simulta- behavior between patients with and without tu- neously. Additionally, one of these patients had a berous sclerosis. partial nephrectomy 6 years later for a contralateral angiomyolipoma. In 19 cases, both neoplasms oc- curred in the left kidney, in 10 they occurred in the right kidney, and in 4, the side was not specified. MATERIALS AND METHODS One patient had a renal-cell neoplasm in the left Surgical pathology records of nine institutions side and bilateral angiomyolipomas, and two pa- and the consultation files of the authors were tients had bilateral renal-cell neoplasms and an searched for the diagnosis of renal angiomyoli- angiomyolipoma in the left kidney. One of the pa- poma. Patients that had coexistent, precedent, or tients with bilateral renal-cell neoplasms had subsequent renal-cell neoplasia were included in autosomal-dominant polycystic kidney disease. the study. Eleven patients (31%) had tuberous sclerosis. Of Clinical information was obtained from the pa- these, only six had a clinical diagnosis of tuberous tients’ medical records and treating physicians and sclerosis; in the remaining five, the diagnosis was included age at presentation, gender, any personal made based on the presence of multiple angiomyo- or family history of tuberous sclerosis, and lipomas (47). The mean ages for the sporadic and tuberous sclerosis-related cases, respectively, were follow-up information. A patient was considered to ϭ have tuberous sclerosis if there was a clinical diag- 59 and 53 years (P .365), and the female-to-male nosis of the disease or, according to Gomez’ criteria ratios were 2:1 and 5:1. Twenty-eight cases were (47), if there were multiple angiomyolipomas. He- matoxylin and eosin–stained sections of each neo- TABLE 1. Clinical Features of 34 Cases of Coexistent plasm were reviewed. Renal epithelial neoplasms Renal Cell Neoplasia and Angiomyolipoma Sporadic Setting Tuberous Sclerosis were classified according to the Rochester classifi- Variable cation (48). Other pathologic features noted in- (n ϭ 25) (n ϭ 11) cluded size of the tumor and multifocality. Fuhr- Mean age (y) 59 53 F:M 2:1 5:1 man nuclear grade and 1997 UICC/AJCC TNM Side of angiomyolipoma (n) pathologic stage were determined for malignant Right 9 1 renal-cell neoplasms. Size, histologic type, and Left 13 8 Bilateral 0 1 multifocality of angiomyolipoma were recorded. Not specified 3 1 Because many of the cases were seen in consulta- Side of renal cell neoplasm (n) tion and all of the cases were retrieved retrospec- Right 8 2 Left 12 8 tively from nine institutions, gross sampling of tu- Bilateral 2 0 mors was not performed in any predictable, Not specified 3 1 standardized manner. Multifocality (n) Angiomyolipoma 0 11 At least one block from each neoplasm (available Renal cell neoplasm 7 0 for 22 renal-cell neoplasms and 25 angiomyolipo- Surgery type (n) mas) was retrieved, and sections were submitted for Total nephrectomy 21 7 Partial nephrectomy 3 4 immunohistochemical staining for monoclonal Partial and radical 10 HMB-45 (DAKO, Carpenteria, CA; dilution, 1:40). nephrectomy Statistical analysis was done with SPSS software, Size angiomyolipoma (cm) Mean 1.0 3.3 Version 7.0, for Windows 98. Fisher’s Exact test was Median 0.5 3.0 used to analyze frequency data, whereas the Stu- Size renal cell neoplasm (cm) dent’s t test was used for numerical data. P values of Mean 5.2 5.6 less than .05 were considered significant. Median 3.8 5.0 158 Modern Pathology managed with total nephrectomy (Fig. 1), seven TABLE 2. Distribution of Cases by Histologic Subtype and Clinical Setting with partial nephrectomy, and one with a radical and a contralateral partial nephrectomy. In both Histologic Subtype Sporadic Setting Tuberous Sclerosis sporadic and tuberous sclerosis–associated pa- Benign Papillary adenoma 2* — tients, angiomyolipoma was more commonly the Metanephric adenoma — 1 incidentally found tumor. This was also true within Oncocytoma 2† 3 the category of tuberous sclerosis–associated pa- Malignant Clear-cell RCC 15* 6 tients (those with clinical history of tuberous scle- Papillary RCC 2 — rosis versus those assigned as tuberous sclerosis Chromophobe RCC 4 — based on Gomez’ criteria of multifocality). Collecting-duct RCC 1 — For angiomyolipomas occurring sporadically, the Unclassified RCC — 1 mean and median sizes were 1.0 and 0.5 cm, re- RCC, renal cell carcinoma.
Load more

Recommended publications
  • Aborted Sudden Death in a Young Male SELF ASSESSMENT
    664 Postgrad Med J 2003;79:664–666 Postgrad Med J: first published as 10.1136/pmj.79.937.666 on 3 December 2003. Downloaded from SELF ASSESSMENT ANSWERS Aborted sudden death in a Q2: What is the pathophysiological basisofthiscondition? What further young male diagnostic tests would you consider doing in this patient? Q1: What is the ECG (fig 1; p 660) Genetic studies have shown that Brugada diagnosis? Why is it important to syndrome and chromosome 3-linked long QT recognise this condition? syndrome (LQT3) are allelic disorders of the The ECG done on his arrival at the emergency cardiac channel gene (SCN5A, 3p21). The room (see questions) shows (i) sinus tachy- inheritance is autosomal dominant with cardia, (ii) a QRS complex that ends with a variable penetrance. The SCN5A gene codes positive deflection (or prominent J wave) for the alpha subunit of the sodium channel. that is, a rsR9 pattern in V1 and V2, and (iii) Mutations of this gene results in abnormal- an elevated downsloping ST segment ending ities of the sodium channel, with abnormal in a small negative T-wave deflection. This ion conductance patterns and can be demon- ECG pattern in someone with a history of strated in up to 25% Brugada syndrome syncopy and documented ventricular fibrilla- cases.235 Brugada-type downsloping ST seg- tion/aborted sudden death, is most consistent ment is a normal feature of the ECG in some with the eponymous Brugada syndrome. rodents, whereas in higher mammals, the ST Described first in 1992 by Brugada and segment is usually isoelectric in the normal Brugada, Brugada syndrome is an inherited state.
    [Show full text]
  • Angiomyolipoma of the Cervix – Report of a Rare Entity
    Internet Journal of Medical Update. 2017 July;12(2):13-15. doi: 10.4314/ijmu.v12i2.4 Internet Journal of Medical Update Journal home page: http://www.akspublication.com/ijmu Case Report Angiomyolipoma of the cervix – report of a rare entity N. Hariharanadha Sarmaᴪ1, Rama Srivastava2, Smriti Agnihotri3 1Consultant Pathologist, Department of Pathology, RDT Hospital, Bathalapalli, Andhra Pradesh, India 2Professor, Department of Pathology, SSR Medical College, Belle Rive, Mauritius 3Professor, Department of Pathology, American University of Antigua College of Medicine, Antigua & Barbuda, WI (Received 22 September 2017 and accepted 04 October 2017) ABSTRACT: Angiomyolipoma (AML) is a mesenchymal neoplasm seen usually in the kidney. Few cases of extra renal AML have been documented in various organs including the female genital tract, where the uterus is the most common site. To the best of our knowledge, only 4 cases of AML in the cervix have been reported in the literature. Association of AML with tuberous sclerosis is well known. Presently AML is included in the spectrum of disease entities called PEComa. We report a case of AML without tuberous sclerosis arising from the uterine cervix, which has to be differentiated from lipoleiomyoma. KEY WORDS: Angiomyolipoma; Uterine cervix; PEComas; Uterine tumor INTRODUCTIONV localization8, and mostly in females over 409. The occurrence of AML in the cervix without Angiomyolipoma (AML) occurs most frequently in concurrent incidence in the kidney is extremely the kidney, where it is closely related to tuberous rare, and only four cases have been reported in the sclerosis complex (TSC)1,2, occasionally in other scientific literature10. We are reporting a case of organs, most commonly the liver, but occurrence at uterine cervix AML without tuberous sclerosis other sites is extremely rare3.
    [Show full text]
  • Soft Tissue Cytopathology: a Practical Approach Liron Pantanowitz, MD
    4/1/2020 Soft Tissue Cytopathology: A Practical Approach Liron Pantanowitz, MD Department of Pathology University of Pittsburgh Medical Center [email protected] What does the clinician want to know? • Is the lesion of mesenchymal origin or not? • Is it begin or malignant? • If it is malignant: – Is it a small round cell tumor & if so what type? – Is this soft tissue neoplasm of low or high‐grade? Practical diagnostic categories used in soft tissue cytopathology 1 4/1/2020 Practical approach to interpret FNA of soft tissue lesions involves: 1. Predominant cell type present 2. Background pattern recognition Cell Type Stroma • Lipomatous • Myxoid • Spindle cells • Other • Giant cells • Round cells • Epithelioid • Pleomorphic Lipomatous Spindle cell Small round cell Fibrolipoma Leiomyosarcoma Ewing sarcoma Myxoid Epithelioid Pleomorphic Myxoid sarcoma Clear cell sarcoma Pleomorphic sarcoma 2 4/1/2020 CASE #1 • 45yr Man • Thigh mass (fatty) • CNB with TP (DQ stain) DQ Mag 20x ALT –Floret cells 3 4/1/2020 Adipocytic Lesions • Lipoma ‐ most common soft tissue neoplasm • Liposarcoma ‐ most common adult soft tissue sarcoma • Benign features: – Large, univacuolated adipocytes of uniform size – Small, bland nuclei without atypia • Malignant features: – Lipoblasts, pleomorphic giant cells or round cells – Vascular myxoid stroma • Pitfalls: Lipophages & pseudo‐lipoblasts • Fat easily destroyed (oil globules) & lost with preparation Lipoma & Variants . Angiolipoma (prominent vessels) . Myolipoma (smooth muscle) . Angiomyolipoma (vessels + smooth muscle) . Myelolipoma (hematopoietic elements) . Chondroid lipoma (chondromyxoid matrix) . Spindle cell lipoma (CD34+ spindle cells) . Pleomorphic lipoma . Intramuscular lipoma Lipoma 4 4/1/2020 Angiolipoma Myelolipoma Lipoblasts • Typically multivacuolated • Can be monovacuolated • Hyperchromatic nuclei • Irregular (scalloped) nuclei • Nucleoli not typically seen 5 4/1/2020 WD liposarcoma Layfield et al.
    [Show full text]
  • The Health-Related Quality of Life of Sarcoma Patients and Survivors In
    Cancers 2020, 12 S1 of S7 Supplementary Materials The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of A Nationwide Observational Study (PROSa) Martin Eichler, Leopold Hentschel, Stephan Richter, Peter Hohenberger, Bernd Kasper, Dimosthenis Andreou, Daniel Pink, Jens Jakob, Susanne Singer, Robert Grützmann, Stephen Fung, Eva Wardelmann, Karin Arndt, Vitali Heidt, Christine Hofbauer, Marius Fried, Verena I. Gaidzik, Karl Verpoort, Marit Ahrens, Jürgen Weitz, Klaus-Dieter Schaser, Martin Bornhäuser, Jochen Schmitt, Markus K. Schuler and the PROSa study group Includes Entities We included sarcomas according to the following WHO classification. - Fletcher CDM, World Health Organization, International Agency for Research on Cancer, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. 468 p. (World Health Organization classification of tumours). - Kurman RJ, International Agency for Research on Cancer, World Health Organization, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014. 307 p. (World Health Organization classification of tumours). - Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours. Eur Urol. 2016 Jul;70(1):106–19. - World Health Organization, Swerdlow SH, International Agency for Research on Cancer, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: [... reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25 - 27, 2007]. 4. ed.
    [Show full text]
  • Non-Wilms Renal Cell Tumors in Children
    PEDIATRIC UROLOGIC ONCOLOGY 0094-0143/00 $15.00 + .OO NON-WILMS’ RENAL TUMORS IN CHILDREN Bruce Broecker, MD Renal tumors other than Wilms’ tumor are tastases occur in 40% to 60% of patients with infrequent in childhood. Wilms’ tumors ac- clear cell sarcoma of the kidney, whereas they count for 6% to 7% of childhood cancer, are found in less than 2% of patients with whereas the remaining renal tumors account Wilms’ tumor.**,26 This distinct clinical behav- for less than l%.27The most common non- ior is one of the features that has led to its Wilms‘ tumors are clear cell sarcoma of the designation as a separate tumor. Other clini- kidney, rhabdoid tumor of the kidney (both cal features include a lack of association with formerly considered unfavorable Wilms’ tu- sporadic aniridia or hemihypertrophy. mor variants but now considered separate tu- Clear cell sarcoma of the kidney has not mors), renal cell carcinoma, mesoblastic been reported to occur bilaterally and is not nephroma, and multilocular cystic nephroma. associated with nephroblastomatosis. It has Collectively, these tumors account for less been reported in infancy and adulthood, but than 10% of the primary renal neoplasms in the peak incidence is between 3 and 5 years childhood. of age. It has an aggressive behavior that responds poorly to treatment with vincristine and actinomycin alone, leading to its original CLEAR CELL SARCOMA designation by Beckwith as an unfavorable histology pattern. The addition of doxorubi- Clear cell sarcoma of the kidney is cur- cin in aggressive chemotherapy regimens has rently considered a separate tumor distinct improved outcome.
    [Show full text]
  • Appendix 4 WHO Classification of Soft Tissue Tumours17
    S3.02 The histological type and subtype of the tumour must be documented wherever possible. CS3.02a Accepting the limitations of sampling and with the use of diagnostic common sense, tumour type should be assigned according to the WHO system 17, wherever possible. (See Appendix 4 for full list). CS3.02b If precise tumour typing is not possible, generic descriptions to describe the tumour may be useful (eg myxoid, pleomorphic, spindle cell, round cell etc), together with the growth pattern (eg fascicular, sheet-like, storiform etc). (See G3.01). CS3.02c If the reporting pathologist is unfamiliar or lacks confidence with the myriad possible diagnoses, then at this point a decision to send the case away without delay for an expert opinion would be the most sensible option. Referral to the pathologist at the nearest Regional Sarcoma Service would be appropriate in the first instance. Further International Pathology Review may then be obtained by the treating Regional Sarcoma Multidisciplinary Team if required. Adequate review will require submission of full clinical and imaging information as well as histological sections and paraffin block material. Appendix 4 WHO classification of soft tissue tumours17 ADIPOCYTIC TUMOURS Benign Lipoma 8850/0* Lipomatosis 8850/0 Lipomatosis of nerve 8850/0 Lipoblastoma / Lipoblastomatosis 8881/0 Angiolipoma 8861/0 Myolipoma 8890/0 Chondroid lipoma 8862/0 Extrarenal angiomyolipoma 8860/0 Extra-adrenal myelolipoma 8870/0 Spindle cell/ 8857/0 Pleomorphic lipoma 8854/0 Hibernoma 8880/0 Intermediate (locally
    [Show full text]
  • Genitourinary PAX8
    174A ANNUAL MEETING ABSTRACTS RMC and 19/21 (90%) of CDC cases. In contrast, 31/34 (91%) UUC were negative for Genitourinary PAX8. p63: p63 was positive in 7/12 (58%) RMC and in 3/21 (14%) CDC. Staining was focal in 6/7 RMC and strong in 4/7. Almost all (97%) UUC were p63 positive 767 Histopathologic Features of Bilateral Renal Cell Carcinomas: A (moderate/strong and multifocal/diffuse in 80% of cases). The one p63 negative UUC Study of 24 Cases was a microinvasive high grade tumor and was also negative for PAX8. J Abdelsayed, JY Ro, LD Truong, AG Ayala, SS Shen. The Methodist Hospital and Weill Conclusions: We suggest a binary panel of PAX8 and p63 as an aid in the differential Medical College of Cornell University, Houston, TX. diagnosis of high grade renal sinus epithelial neoplasms. (PAX8+/p63+) profile Background: The incidence of bilateral renal cell carcinoma (bRCC) has been reported supported the dx of RMC with a sensitivity of 58.3% and specificity of 89%. (PAX8+/ to vary from 1.5% to 11%. Clear understanding of the clinicopathologic features of p63-) profile supported the diagnosis of CDC with a sensitivity of 85.7% and a specificity bRCCs including the distinction between synchronous and metachronous tumors has of 89%. Finally (PAX8-/p63+) profile supported the diagnosis of UUC with a sensitivity important implications in patients’ management and follow up. The purpose of this study of 88% and a specificity of 100%. The concomitant expression of p63 and PAX8 in RMC is to summarize the clinicopathologic features of bRCCs and compare them with those seen in our study further suggests an intermediate phenotype between renal tubular and of unilateral renal cell carcinomas (uRCCs).
    [Show full text]
  • A Metanephric Adenoma of the Kidney Associated with Polycythemia: a Case Report
    352 ONCOLOGY LETTERS 11: 352-354, 2016 A metanephric adenoma of the kidney associated with polycythemia: A case report PENGFEI WANG, YUAN TIAN, YUEHAI XIAO, YANG ZHANG, FA SUN and KAIFA TANG Department of Urology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China Received January 11, 2015; Accepted September 24, 2015 DOI: 10.3892/ol.2015.3868 Abstract. Metanephric adenoma (MA) of the kidney is a 54-year-old female that presented with MA associated with rare and frequently benign tumor with a favorable prognosis polycythemia. that is often diagnosed following surgical treatment. In the present study, a 54-year-old female patient presented with Case Report complaints of intermittent right-flank pain and anterior abdominal pain occurring over 2 years and sporadic gross A 54-year-old female patient presented to the Affiliated hematuria occurring over 3 months. Ultrasonography and Hospital of Guizhou Medical University (Guiyang, China), computerized tomography imaging revealed a neoplasm with complaints of intermittent right flank pain and ante- lesion localized in the right kidney. Successful open approach rior abdominal pain that occurred over a 2-year period and radical nephrectomy was performed and post-surgical histo- sporadic gross hematuria that occurred over 3 months in pathological examination verified the lesion as a MA of the March 2013. The patient had no other symptoms. Physical kidney. Radical nephrectomy, cryoablation or radiofrequency examination revealed no significant conclusions. Urinalysis may used to treat MA and a selective panel of immunostains, revealed hematuria in the urine culture and a routine including WT1, EMA and AMACR, may be useful for diag- blood examination exhibited a hematocrit (Hct) volume of nosis.
    [Show full text]
  • TSC Facts Countdown for 15 Days in May: 1. Tuberous Sclerosis Complex
    TSC Facts Countdown for 15 days in May: 1. Tuberous sclerosis complex (TSC) is a genetic disorder with no cure that causes non-cancerous tumors to form in vital organs. 2. Tuberous sclerosis complex (TSC) is estimated to affect 1 in 6,000 live births. Globally, one million individuals have TSC, making it as common as cystic fibrosis or amyotrophic lateral sclerosis (ALS). 3. Approximately ⅔ of individuals diagnosed with tuberous sclerosis complex (TSC) have no family history. The remaining ⅓ of individuals diagnosed with TSC have a parent who also has TSC. 4. If one parent is diagnosed with tuberous sclerosis complex (TSC), the probability of his or her children inheriting the disease is 50%. If parents are unaffected by TSC and have one child with TSC, the probability of having another child with TSC is around 1-2%. 5. Tuberous sclerosis complex (TSC) is the leading genetic cause of both epilepsy and autism spectrum disorders. Seizures occur in approximately 85% of individuals with TSC and intellectual disabilities are found in 45-60%. 6. Approximately 98% of individuals experience one or more skin manifestations (such as angiofibromas) of tuberous sclerosis complex (TSC). 7. Up to 60% of individuals experience kidney involvement with tuberous sclerosis complex (TSC). 8. Tuberous sclerosis complex (TSC) affects men and women in equal numbers and occurs in all races and ethnic groups. 9. Tuberous sclerosis complex (TSC) affects everyone differently; some may have mild symptoms while others are severely impacted. TSC symptoms often vary over a person’s lifetime—someone who has few childhood symptoms may still have severe health problems later in life.
    [Show full text]
  • Your Kidneys and Kidney Cancer
    Your Kidneys and Kidney Cancer DID YOU KNOW? Kidney Disease Kidney Cancer Having advanced Having kidney cancer kidney disease or a can increase your risk About 1/3 of kidney cancer kidney transplant can for kidney disease or patients have or will develop increase your risk for kidney failure. kidney disease.2 kidney cancer. TOP Kidney cancer is among the 10 10 most common cancers in both men and women.1 KIDNEYS Your kidneys’ main job is to About 62,000 kidney cancers clean waste and extra water 62,000 occur in the U.S. each year.1 from your blood. Having kidney disease means your kidneys are damaged and cannot do this job well. KIDNEY CANCER Over time, kidney disease can get worse and lead to kidney failure. Once kidneys fail, treatment with dialysis or a Kidney cancer is a disease that kidney transplant is needed starts in the kidneys. It happens to stay alive. when kidney cells grow out of control and form a lump (called a “tumor”). The cancer may stay in your kidneys or spread to other parts of your body. 1 Your Kidneys and Kidney Cancer SYMPTOMS Most people don’t have symptoms in the early stages of kidney disease or kidney cancer. Advanced Kidney Cancer Advanced Kidney Disease Blood in the urine Feeling tired or short of breath Pain on the sides of the mid-back Loss of appetite A lump in the abdomen Dry, itchy skin (stomach area) Trouble thinking clearly Weight loss, night sweats, unexplained fever Frequent urination Swollen feet and ankles, Tiredness puiness around eyes Talk to Your Healthcare Provider About your risk for kidney cancer About your risk for kidney disease CANCER TREATMENTS Some cancer treatments can increase your risk for kidney disease or kidney failure.
    [Show full text]
  • Metanephric Adenoma with Diffuse Calcifications: a Case Report
    1816 ONCOLOGY LETTERS 10: 1816-1818, 2015 Metanephric adenoma with diffuse calcifications: A case report JINGTAO WU*, QINGQIANG ZHU*, WENRONG ZHU and HONGYING ZHANG Department of Medical Imaging, Subei People's Hospital, Medical School of Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China Received September 2, 2014; Accepted April 29, 2015 DOI: 10.3892/ol.2015.3491 Abstract. Metanephric adenoma is a rare and benign renal to the development of less invasive treatment strategies in the neoplasm originating in the epithelial cells of the kidney. future. The current study presents the case of a male patient The tumor has a benign course and a characteristic histo- diagnosed with atypical metanephric adenoma with diffuse pathological appearance, typically exhibiting a solid and calcifications who subsequently underwent radical nephrectomy. poorly-demarcated margin with rare cystic components or calcifications. However, it is often difficult to distinguish Case report metanephric adenoma from malignant neoplasms prior to surgical resection. To the best of our knowledge, only one case A 23‑year‑old male patient was admitted to Subei People's of metastasis to the lymph nodes has been described in the Hospital (Yangzhou, China) with a history of flank pain literature thus far. The present study retrospectively analyzed on October 23, 2013, and appeared in good general condi- one case of surgically and pathologically‑confirmed atypical tion. The patient had no history of occupational exposure metanephric adenoma. Clinical and pathological analysis, as to carcinogens.At >1 month after the onset of symptoms, a well as computed tomography scans, revealed a mass with a medical examination identified a left renal mass with diffuse clearly defined margin and diffuse calcifications.
    [Show full text]
  • Tuberous Sclerosis in Early Infancy: a Case Report H
    Brief Report Tuberous Sclerosis in Early Infancy: A Case Report H. John Blossom, MD Fresno, California The diagnosis of tuberous sclerosis in an infant was de­ sclerosis contributed to the delay. A brief review of the layed by 3 months. Failure to take an adequate padent case and the diagnosis of tuberous sclerosis is presented. history because of a language barrier between parents and Key words: Tuberous sclerosis; seizures; infant care. caregivers and to observe the classic stigmata of tuberous / Pam Proa 1993; 36:344-346. The occurrence of seizures in an infant is a frightening evaluation was apparently delayed because of a diagnosis experience for parents and physicians alike. In this case of persistent otitis media, which required repeat admin­ report important historical information and unique phys­ istrations of antibiotics. ical findings arc described that helped determine the During the infant’s 4th month of life, several visits cause of seizures in a 4-month-old infant. to physicians were made for fussiness and fever. Otitis media was diagnosed several times. In addition, the par­ ents observed and reported an abnormality in the baby’s Case Report behavior that they described in Spanish as ataques, a term commonly used to describe fits or seizures. During clin­ The infant weighed 9 lb 3 oz at birth. His mother had an ical encounters interpreters translated conversations be­ uncomplicated prenatal course and an uneventful deliv­ tween the physicians and the parents. Because the ataques ery. The infant’s Apgar scores were 8/8 at 1 and 5 were of very brief duration and no abnormal physical minutes.
    [Show full text]